SenoRx Announces First Quarter 2010 Conference Call and Webcast

SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its First Quarter 2010 financial results on Thursday, May 6 at 8:00 a.m. PDT (11:00 a.m. EDT). The call will be open to all investors live via the Investor Relations section of the SenoRx web site at http://investor.senorx.com/events.cfm. A replay of the call will be available on the company's web site approximately 90 minutes after the call concludes. SenoRx's financial results press release is expected to be released after market close on Wednesday, May 5.

Details:

What:

 

SenoRx's First Quarter 2010 Investor Conference Call and Webcast

Date:

 

Thursday, May 6

Time:

 

8:00 a.m. PDT/11:00 a.m. EDT

How:

 

Via telephone: Domestic:  877-369-1866; International: 678-894-3966

 

 

Via Internet:      http://investor.senorx.com/events.cfm

SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor® vacuum-assisted breast biopsy system and Contura™ MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.

CONTACT: SenoRx, Inc.

Lila Churney, Director of Investor Relations

949-362-4800 x132